WebJan 15, 2024 · Novasep was founded more than 20 years ago. It had about 400 employees. Estimated 2024 revenue was about $95 million. “Thermo Fisher is an outstanding partner … WebFeb 18, 2024 · Shortly after Thermo Fisher's $878.2 million buyout of Novasep's viral vector manufacturing business, it took over a plant in Belgium tasked with producing adenovirus vectors for AstraZeneca's ...
05 - Thermo Fisher Scientific Completes Acquisition of PeproTech, …
WebJan 18, 2024 · Thermo Fisher Scientific announced on Jan. 15, 2024 that it has completed its acquisition of Henogen, Novasep’s viral vector manufacturing business in Belgium, for EUR 725 million (US$875 million) in cash. Henogen will be integrated into Thermo Fisher’s Pharma Services business within its Laboratory Products and Services segment, Thermo ... WebJan 15, 2024 · WALTHAM, Mass. and LYON, France, Jan. 15, 2024 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe … iowa non resident hunting license cost
Pressure Driven Operation Membrane Filters Market Study
WebJan 15, 2024 · Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing and complex active molecule services for pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries. … WebJan 15, 2024 · Jan 15 (Reuters) - Medical device maker Thermo Fisher Scientific Inc said on Friday it has completed acquisition of Henogen SA, a Belgium-based viral vector manufacturing business, for about... WebJan 19, 2024 · French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech. opencl ps